Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone marrow-derived cell therapies for acute and chronic traumatic spinal cord injury
RBR-67qc83xCompleted
- Sponsor
- Instituto Educacional Jaguary
- Start
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of monosialotetrahexosylganglioside in spinal cord injury (SCI) (4 arms), sponsored by Instituto Educacional Jaguary. Started Mar 2025; status: completed.
02
Drugs
monosialotetrahexosylganglioside
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on RBR-67qc83x.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-67qc83x.